The anti-platelet drug cilostazol enhances heart rate and interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0292858 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Wei-Chun Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Tunghai University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Zebrafish, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Rationale
Cilostazol, an anti-platelet phosphodiesterase-3 inhibitor used for the treatment of intermittent claudication, is known for its pleiotropic effects on platelets, endothelial cells and smooth muscle cells. However, how cilostazol impacts the endocrine system and the injury-induced inflammatory processes remains unclear.
Methods
We used the zebrafish, a simple transparent model that demonstrates rapid development and a strong regenerative ability, to test whether cilostazol influences heart rate, steroidogenesis, and the temporal and dosage effects of cilostazol on innate immune cells during tissue damage and repair.
Results
While dosages of cilostazol from 10 to 100 μM did not induce any noticeable morphological abnormality in the embryonic and larval zebrafish, the heart rate was increased as measured by ImageJ TSA method. Moreover, adrenal/interrenal steroidogenesis in larval zebrafish, analyzed by whole-mount 3β-Hsd enzymatic activity and cortisol ELISA assays, was significantly enhanced. During embryonic fin amputation and regeneration, cilostazol treatments led to a subtle yet significant effect on reducing the aggregation of Mpx-expressing neutrophil at the lesion site, but did not affect the immediate injury-induced recruitment and retention of Mpeg1-expressing macrophages.
Conclusions
Our results indicate that cilostazol has a significant effect on the heart rate and the growth as well as endocrine function of steroidogenic tissue; with a limited effect on the migration of innate immune cells during tissue damage and repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Tunghai University, Taichung, Taiwan.
- Feng Yuan Hospital of the Ministry of Health and Welfare, Taichung, Taiwan.
- Department of Bioscience Technology, Chung Yuan Christian University, Chung-Li, Taiwan.
- Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan.
- Department of Medical Science, National Tsing Hua University, Hsinchu, Taiwan.
ORCID-Profile: Yu-Fu Chen, Yi-Wen Liu
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Chang, W. C., Chen, M. J., Hsiao, C. D., Hu, R. Z., Huang, Y. S., Chen, Y. F., Yang, T. H., Tsai, G. Y., Chou, C. W., Chen, R. S., Chuang, Y. J., & Liu, Y. W. (2023). The anti-platelet drug cilostazol enhances heart rate and interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish. PLOS ONE. https://doi.org/10.1371/journal.pone.0292858
Vancouver
Chang WC, Chen MJ, Hsiao CD, Hu RZ, Huang YS, Chen YF, et al. The anti-platelet drug cilostazol enhances heart rate and interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish. PLOS ONE. 2023. doi:10.1371/journal.pone.0292858
BibTeX
@article{Chang2023,
author = {Chang, Wei-Chun and Chen, Mei-Jen and Hsiao, Chung-Der and Hu, Rong-Ze and Huang, Yu-Shan and Chen, Yu-Fu and Yang, Tsai-Hua and Tsai, Guan-Yi and Chou, Chih-Wei and Chen, Ren-Shiang and Chuang, Yung-Jen and Liu, Yi-Wen},
title = {The anti-platelet drug cilostazol enhances heart rate and interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0292858}
}
EUVIMED